Evidence map›Paper›PMID 33149211›Full record

ArticleScientific reports2020

Preconditioning the immature lung with enhanced Nrf2 activity protects against oxidant-induced hypoalveolarization in mice.

Chandra M Tamatam, Narsa M Reddy, Haranatha R Potteti, Aparna Ankireddy, Patrick M Noone, Masayuki Yamamoto, Thomas W Kensler, Sekhar P Reddy

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Molecular mechanisms of cell death in bronchopulmonary dysplasia.Apoptosis : an international journal on programmed cell death · 2023
    Review
  12. Review
  13. Review
  14. Review
  15. Role of NRF2 in immune modulator expression in developing lung.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Chandra M TamatamDepartment of Pediatrics, University of Illinois at Chicago, Chicago, IL, 60612, USA. tamatam@uic.edu.
Narsa M ReddyDepartment of Pediatrics, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Haranatha R PottetiDepartment of Pediatrics, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Aparna AnkireddyDepartment of Pediatrics, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Patrick M NooneDepartment of Pediatrics, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Masayuki YamamotoDepartment of Medical Biochemistry, Tohoku University, Sendai, Japan.ORCID 0000-0002-9073-9436
Thomas W KenslerTranslational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.ORCID 0000-0002-6676-261X
Sekhar P ReddyDepartment of Pediatrics, University of Illinois at Chicago, Chicago, IL, 60612, USA. sreddy03@uic.edu.
University of Illinois Chicago · USFred Hutch Cancer Center · USNorthwestern University · USTohoku University · JP

Funding

Targeting Nrf2 for Cancer ChemopreventionR35CA197222 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KENSLER, THOMAS W · 2015 to 2021
$6.7M
Human NRF2 Promoter Functional Polymorphisms and Acute Lung InjuryR01HL066109 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REDDY, SEKHAR P. · 2001 to 2012
$3.5M
Role of Nrf2 in Alveolar Epithelial Cell Regeneration During Lung RepairR01HL136946 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REDDY, SEKHAR P. · 2017 to 2020
$2.1M
NCI NIH HHS R35 CA197222NHLBI NIH HHS HL136946NHLBI NIH HHS HL66109NHLBI NIH HHS R01 HL066109NHLBI NIH HHS R01 HL136946
6 · The paper itself

Abstract

Bronchopulmonary dysplasia (BPD) is a chronic disease of preterm babies with poor clinical outcomes. Nrf2 transcription factor is crucial for cytoprotective response, whereas Keap1-an endogenous inhibitor of Nrf2 signaling-dampens these protective responses. Nrf2-sufficient (wild type) newborn mice exposed to hyperoxia develop hypoalveolarization, which phenocopies human BPD, and Nrf2 deficiency worsens it. In this study, we used PND1 pups bearing bearing hypomorphic Keap1 floxed alleles (Keap1

Indexed as

AnimalsAnimals, NewbornBronchopulmonary DysplasiaCell ProliferationCytoprotectionDisease Models, AnimalDNA DamageGene Expression RegulationGene Knockdown TechniquesHyperoxiaKelch-Like ECH-Associated Protein 1LungMiceMice, KnockoutNF-E2-Related Factor 2OxidantsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Oxidants

Identifiers

PMID33149211
PMCPMC7642393
OpenAlexW3095107698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.